Chronological and Biological Aging in Amyotrophic Lateral Sclerosis and the Potential of Senolytic Therapies
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Amyotrophic Lateral Sclerosis (ALS) shares aging hallmarks like DNA damage and inflammation. Targeting cellular senescence may offer new ALS treatments by reducing neuroinflammation.
Area Of Science
- Neurodegenerative Disorders
- Aging Biology
Background
- Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease with limited treatment options.
- ALS incidence increases with age, suggesting a link between aging and disease onset.
- Both sporadic and genetic ALS share aging hallmarks like DNA damage, mitochondrial dysfunction, and cellular senescence.
Purpose Of The Study
- To explore the relationship between chronological and biological aging in ALS.
- To investigate shared pathophysiological mechanisms between aging and ALS.
- To identify potential therapeutic targets for ALS based on aging processes.
Main Methods
- Review of existing literature on ALS pathogenesis and aging hallmarks.
- Analysis of shared molecular and cellular pathways in aging and ALS.
- Exploration of senescence-associated secretory phenotype and senolytic therapies.
Main Results
- Aging hallmarks, including DNA damage, mitochondrial dysfunction, and cellular senescence, are implicated in ALS.
- Age-related muscle weakness and motor unit loss parallel ALS pathology.
- Senescence-associated secretory phenotype and senolytic treatments show promise for ALS intervention.
Conclusions
- Aging processes significantly contribute to ALS onset and progression.
- Shared mechanisms between aging and ALS offer novel therapeutic strategies.
- Senolytic therapies targeting cellular senescence may mitigate neuroinflammation and modify ALS progression.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
When ATP, that is attached to the myosin head, is hydrolyzed to ADP, myosin moves into a high energy state bound to actin, creating a cross-bridge. When ADP is...